Notice and sympathetic neurotransmission

Cardiovascular Drugs and Therapy

Volumn 10, Issue 6, 1997, Pages 657-665

  Haass, Markus ^a   Kübler, Wolfgang ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Epinephrine; Intracellular calcium; Intracellular sodium; Myocardial ischemia; Neuropeptide Y; Nicotine; Nicotinic acetylcholine receptor; Norepinephrine; Protein kinase C; Voltage dependent calcium channel

Indexed keywords

ADRENALIN; CALCIUM CHANNEL; CALCIUM ION; CATION CHANNEL; NICOTINE; NICOTINIC RECEPTOR; NORADRENALIN; SODIUM ION;

ADRENAL MEDULLA; ADRENERGIC TRANSMISSION; BINDING SITE; BLOOD PRESSURE; CALCIUM TRANSPORT; CATECHOLAMINE RELEASE; CONFORMATIONAL TRANSITION; HEART MUSCLE CONTRACTILITY; HEART RATE; NERVE ENDING; PRIORITY JOURNAL; REVIEW; SODIUM TRANSPORT; SYMPATHETIC NERVE; ADRENERGIC SYSTEM; ANIMAL; DRUG EFFECT; ENERGY METABOLISM; HEART; HEART MUSCLE; HUMAN; METABOLISM; SYNAPTIC TRANSMISSION;

ANIMALS; ENERGY METABOLISM; HEART; HUMANS; MYOCARDIUM; NICOTINE; NOREPINEPHRINE; RECEPTORS, NICOTINIC; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION;

EID: 0030623464     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00053022     Document Type: Review

References (55)

1. 2+ signalling takes the local route. Curr Opin Neurobiol 1992;2:302-307.
2. Benowitz NL, Porchet H, Sheiner L, Jacob P. Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum. Clin Pharmacol Ther 1988;44:23-28.
3. Benowitz NL. Nicotine and coronary heart disease. Trends Cardiovasc Med 1991;1:315-321.
4. Bertrand D, Galzi JL, Devillers-Thiery A, Bertrand S, Changeux J-P. Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal α7 nicotinic receptor. Proc Natl Acad Sci USA 1993;90: 6971-6975.
5. + agents, that stimulate catecholamine secretion, in isolated adrenal chromafftn cells. J Neurochem 1984; 42:607-617.
6. Brooks JC. The isolated bovine adrenomedullary chromaffin cell: A model of neuronal excitation-secretion. Endocrinology 1977;101:1369-1378.
7. Changeux J-P. The TiPS lecture. The nicotinic acetylcholine receptor: An allosteric protein prototype of ligand-gated ion channels. Trends Pharmacol Sci 1990;11:485-492.
8. Cheek TR, Jackson TR, O'Sullivan AJ, Moreton RB, Berridge MJ, Burgoyne MJ, Burgoyne RD. Simultaneous measurements of cytosolic calcium and secretion in single bovine adrenal chromaffin cells by fluorescent imaging of fura-2 in cocultured cells. J Cell Biol 1989;109:1219-1227.
9. Cryer PE, Raymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic effects. N Engl J Med 1976;295:573-577.
10. Deanfield JE, Shea MJ, Wilson RA, Horlock P, deLandsheere CM, Selwyn AP. Direct effects of smoking on the heart: Silent ischemic disturbances of coronary flow. Am J Cardiol 1986;57:1005-1009.
11. i in nicotine-induced norepinephrine release from bovine adrenal chromaffin cells. Am J Physiol 1995;269(Cell Physiol 38): C572-C581.
12. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, Del Bo A, Mancia G. Mechanisms responsible for sympathetic activation by cigarette smoking. Circulation 1994;90:248-253.
13. Haass M, Hock M, Richardt G, Schömig A. Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart. Naunyn-Schmiedebergs Arch Pharmacol 1989;340:509-515.
14. Haass M, Förster C, Richardt G, Kranzhöfer R, Schömig A. Role of calcium channels and protein kinase C for release of norepinephrine and neuropeptide Y. Am J Physiol 1990; 259 (Regulatory Integrative Comp Physiol 28):R925-R930.
15. Haass M, Richardt G, Brenn T, Schömig E, Schömig A. Nicotine-induced release of noradrenaline and neuropeptide Y in guinea-pig heart: Role of calcium channels and protein kinase C. Naunyn-Schmiedebergs Arch Pharmacol 1991; 344:527-531.
16. Haass M, Richardt G, Schömig A. Potentiation of potassium-evoked noradrenaline and neuropeptide Y co-release by cardiac energy depletion: Role of calcium channels and sodium-proton exchange. Naunyn-Schmiedebergs Arch Pharmacol 1992;346:410-418.
17. Haass M, Serf C, Krüger C, Haunstetter A, Vahl Ch-F, Kübler W. Digitalis glycosides stimulate norepinephrine release from the human heart by a dual mechanism of action (abstr). Eur Heart J 1994;15(Suppl):173.
18. Haeusler G, Thoenen H, Haefely W, Huerlimann A. Electrical events in cardiac adrenergic nerves and noradrenaline release from the heart induced by aeetylcholine and KCl. Naunyn-Schmiedebergs Arch Pharmacol Exp Path 1968; 261:389-411.
19. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 1986; 314:271-275.
20. Haunstetter A, Haass M, Yi X, Krüger C, Kübler W. Muscarinic inhibition of cardiac norepinephrine and neuropeptide Y release during ischaemia and reperfusion. Am J Physiol 1994;267 (Regulat Integrat Physiol 36):R1552-R1558.
21. Hernandez-Cruz A, Salia F, Adams PR. Subcellular calcium transients visualized by confocal microscope in a voltage-clamped neuron. Science 1990;247:858-862.
22. Kao L-S, Schneider AS. Calcium mobilization and catecholamine secretion in adrenal chromaffin cells. J Biol Chem 1986;261:4881-4888.
23. Karlin A. Structure of nicotinic acetylcholine receptors. Curr Opin Neurobiol 1993;3:299-309.
24. Kilpatrick DL, Slepetis R, Kirshner N. Ion channels and membrane potential in stimulus-secretion coupling in adrenal medulla cells. J Neurochem 1981;36:1245-1255.
25. Klein LW, Ambrose J, Pichard A, Holt J, Gorlin R, Teichholz LE. Acute coronary hemodynamic response to cigarette smoking in patients with coronary artery disease. J Am Coll Cardiol 1984;3:879-886.
26. + during global ischemia in isolated rat hearts. J Mol Cell Cardiol 1990;22:1259-1272.
27. Kottke TE. Smoking cessation therapy for the patient with heart disease. J Am Coll Cardiol 1993;22:1168-1169.
28. Krüger C, Haunstetter A, Gerber S, Serf C, Kaufmann A, Kübler W, Haass M. Nicotine-induced exocytotic norepinephrine release in guinea-pig heart, human atrium and bovine adrenal chromaffin cells: Modulation by single components of ischemia. J Mol Cell Cardiol 1995;27:1491-1506.
29. Kübler W, Haass M. Cardioprotection: Definition, classification, and fundamental principles. Heart 1996;75:330-333.
30. Kurz T, Richard G, Hagl S, Seyfarth M, Schomig A. Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue. J Mol Cell Cardiol 1995;27:1161-1172.
31. Löffelholz K. Autoinhibition of nicotinic release of noradrenaline from postganglionic sympathetic nerves. Naunyn-Schmiedebergs Arch Pharmacol 1970;267:49-63.
32. Löffelholz K. Release induced by nicotinic agents. In: Paton DM, ed. The Release of Catecholamines from Adrenergic Neurons. Oxford: Pergamon Press, 1979:275-301.
33. McKenna WJ, Chew CY, Oakley CM. Myocardial infarction with normal coronary angiogram: Possible mechanisms of smoking risk in coronary artery disease. Br Heart J 1980; 43:493-498.
34. Moliterno DJ, Willard JE, Lange RA, et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med 1994;330:454-459.
35. Nooney JM, Peters JA, Lambert JJ. A patch clamp study of the nicotinic acetylcholine receptor of adrenomedullary chromaffin cells in culture. J Physiol 1992;455:503-527.
36. Richardt G, Haass M, Neeb S, Hock M, Lang RE, Schömig A. Nicotine-induced release of noradrenaline and neuropeptide Y in guinea pig heart. Klin Wochenschr 1988;66(Suppl XI):21-27.
37. Richardt G, Brenn T, Seyfarth M, Haass M, Schömig E, Schömig A. Dual effect of nicotine on cardiac noradrenaline release during metabolic blockade. Basic Res Cardiol 1994; 89:524-534.
38. Robertson D, Tseng C-J, Appalsamy M. Smoking and mechanisms of cardiovascular control. Am Heart J 1988; 115:258-262.
39. Role LW. Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels. Curr Opinion Neurobiol 1992;4:254-262.
40. Rosenberg J, Benowitz NL, Gacob P, Wilson M. Disposition kinetics and effects of intravenous nicotine. Clin Pharmacol Ther 1980;28:517-522.
41. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 1985;313:1511-1514.
42. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 1990;322:213-217.
43. Sargent PB. The diversity of neuronal nicotinic acetylcholine receptors. Ann Rev Neurosci 1993;16:403-443.
44. Schömig A, Dart AM, Dietz R, Mayer E, Kübler W. Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release. Circ Res 1984;55:689-701.
45. Schömig A, Haass M, Richardt G. Catecholamines and arrhythmias in acute myocardial ischemia. Eur Heart J 1991; 12(Suppl F):38-47.
46. Seyfarth M, Feng Y, Hagl S, Sebening F, Richardt G, Schömig A. Effect of myocardial ischemia on stimulation-evoked noradrenaline release. Modulated neurotransmission in rat, guinea pig, and human cardiac tissue. Circ Res 1993;73:496-502.
47. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-79.
48. Su C, Bevan JA. Blockade of the nicotine-induced norepinephrine release by cocaine, phenoxybenzamine and desipramine. J Pharmacol Exp Ther 1970;175:533-540.
49. Tsien RY. Fluorescent probes of cell signalling. Ann Rev Neurosci 1989;12:227-253.
50. Unwin N. Neurotransmitter action: Opening of ligand-gated ion channels. Cell 1993;72(Suppl):31-41.
51. Verninino S, Amador M, Luetje CW, Patrick J, Dani JA. Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors. Neuron 1992;8: 127-134.
52. 45Ca influx and secretion of catecholamines in cultured bovine adrenal medulla cells. Neuroscience 1985;15:283-292.
53. Westfall TC, Brasted M. The mechanism of action of nicotine on adrenergic neurons in the perfused guinea-pig heart. J Pharmacol Exp Ther 1972;182:409-418.
54. Willett WC, Green A, Stampfer MJ, et al. Relative and absolute excess risks of coronary heart disease among women who smoke. N Engl J Med 1987;317:1303-1309.
55. Winniford MD, Wheelan KR, Kremers MS, et al. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: Evidence for adrenergically mediated alterations in coronary artery tone. Circulation 1986;73:662-667.